drugs

astrazeneca, Bristol-Myers diabetes drug wins US OK - Reuters
The Money Timesastrazeneca, Bristol-Myers diabetes drug wins US OKReutersThe Food and Drug Administration said Onglyza was not linked to increased heart problems in low-risk patients but the agency was requiring future study ...Astra Zeneca gets US approval for diabetes drug OnglyzaTimes OnlineBusiness news in briefPhiladelphia InquirerCan Emerging Markets Save Pharma?Motley Foolall 189 news articles��